Good morning, everyone, and how are you today? We are just fine, thank you, especially as our shortest person has now begun an honest-to-goodness summer job, adding to the sunny outlook of economists everywhere. This calls for a celebratory cup of stimulation and, as always, we invite you to join us. And why not? Firing up some neurons may be a plus. Meanwhile, here are some items of interest. Having a smashing day and do keep in touch …
Prosecutors and defense lawyers went through 134 potential jurors on Monday and failed to find one to sit and judge Martin Shkreli, with many calling him a “snake,” “evil,” and a “d–k,” The New York Post confides. “The defendant is the face of corporate greed in America,” one potential juror said. Shkreli is on trial for securities fraud, but is notorious for buying an old drug and jacking up the price to sky-high levels, and then taunting critics.
About the Author Reprints
@Ed, perhaps evil is too strong a word. For example Hank McKinnell was a nice guy, but did manage a $188 million severance from Pfizer. He even managed to get paid for nearly 500 days of unused vacation.
Ed, they are going about the Shkreli jury selection process the wrong way. By law Pharma Bro is entitled to a jury of his peers. It should not be difficult to find 12 other evil greedy pharmaceutical executives to empanel a jury. I could probably fill the jury box in less than one day if they asked me.
Pharmvet1,
Would like to see the list of those summoned to appear… Suggestions?
ed at pharmalot